131 related articles for article (PubMed ID: 16574293)
1. Improvement of tardive dyskinesia following amisulpride treatment.
Peritogiannis V; Tsouli S; Zafiris S; Pappas D; Mavreas V
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):748-50. PubMed ID: 16574293
[TBL] [Abstract][Full Text] [Related]
2. Tardive dystonia associated with low-dose of amisulpride: a case report.
Sevincok L; Balci V; Akyildiz U
J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
[No Abstract] [Full Text] [Related]
3. Development of tardive dyskinesia in a patient taking amisulpride.
Masdrakis VG; Papadimitriou GN; Papageorgiou C; Kouzoupis A; Giailoglou D; Soldatos CR
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):586-7. PubMed ID: 17196725
[No Abstract] [Full Text] [Related]
4. Amisulpride-induced tardive dystonia: a case report.
Guriz O; Ekinci AE; Orsel S; Ekinci O
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
[No Abstract] [Full Text] [Related]
5. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Croissant B; Hermann D; Olbrich R
Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic bradycardia associated with amisulpride.
Pedrosa Gil F; Grohmann R; Rüther E
Pharmacopsychiatry; 2001 Nov; 34(6):259-61. PubMed ID: 11778148
[TBL] [Abstract][Full Text] [Related]
7. Amisulpride-induced tardive dyskinesia.
Fountoulakis KN; Panagiotidis P; Siamouli M; Kantartzis S; Mavridis T; Iacovides A; Kaprinis G
Schizophr Res; 2006 Dec; 88(1-3):232-4. PubMed ID: 16963229
[TBL] [Abstract][Full Text] [Related]
8. Urinary incontinence associated with amisulpride.
Mendhekar D; Lohia D
World J Biol Psychiatry; 2009; 10(4 Pt 3):1045-6. PubMed ID: 18609424
[No Abstract] [Full Text] [Related]
9. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Cook B; Hoogenboom G
Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
[TBL] [Abstract][Full Text] [Related]
10. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
Chen YY; Huang MC; Wu KC
Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
[No Abstract] [Full Text] [Related]
11. Amisulpride treatment for clozapine-induced sialorrhea.
Praharaj SK; Sarkar S; Sinha VK
J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
[No Abstract] [Full Text] [Related]
12. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
[TBL] [Abstract][Full Text] [Related]
13. Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
Opgen-Rhein C; Neuhaus AH; Dettling M
J Clin Psychopharmacol; 2007 Feb; 27(1):92-3. PubMed ID: 17224723
[No Abstract] [Full Text] [Related]
14. Tardive dyskinesias and antipsychotics: a review.
Llorca PM; Chereau I; Bayle FJ; Lancon C
Eur Psychiatry; 2002 May; 17(3):129-38. PubMed ID: 12052573
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride therapeutic dose-induced asymptomatic bradycardia.
Prikryl R; Ustohal L; Prikrylova-Kucerova H
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):290. PubMed ID: 20965224
[No Abstract] [Full Text] [Related]
16. Tardive oculogyric crisis associated with amisulpride monotherapy.
Mendhekar DN; Lohia D; Kataria P
J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
[TBL] [Abstract][Full Text] [Related]
17. Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
Rettenbacher MA; Hummer M; Fleischhacker WW; Lechleitner M
J Clin Psychiatry; 2004 Jun; 65(6):878-9. PubMed ID: 15291669
[No Abstract] [Full Text] [Related]
18. [Use of metoclopramide hydrochloride in patients with residual schizophrenia with tardive dyskinesias].
Kiehl U; Nitzsche M; Fischer GJ
Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):722-6. PubMed ID: 2869538
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride-induced tardive motor and phonic tics.
Alonso-Navarro H; Jiménez-Jiménez FJ
Clin Neuropharmacol; 2006; 29(3):163-4. PubMed ID: 16772818
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
Hennings JM; Krause E; Bötzel K; Wetter TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]